Combination of susceptibility gene and traditional risk factors might enhance the performance of coronary heart disease screening strategy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28978175)

Published in Oncotarget on March 29, 2017

Authors

Shiyan Nian1, Lei Feng2, Yang Zhao3, Feng Luo3, Shu Zhang3, Dan Li2, Wenbo Xu2, Xingfeng Zhang2, Dan Ye2, Xuejing Bai3

Author Affiliations

1: Intensive Care Unit, People's Hospital of Yuxi City, Yuxi, Yunnan, P.R. China.
2: Department of Laboratory, People's Hospital of Yuxi City, Yuxi, Yunnan, P.R. China.
3: Department of Laboratory, The Sixth Affiliated Hospital of Kunming Medical University, Yuxi, Yunnan, P.R. China.

Articles cited by this

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J Exp Med (1996) 7.97

Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A (1998) 7.69

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet (2003) 6.85

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation (2002) 6.20

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation (2010) 3.87

The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99

Parental history and myocardial infarction risk across the world: the INTERHEART Study. J Am Coll Cardiol (2011) 1.82

Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proc Natl Acad Sci U S A (2003) 1.69

CVD risk factors and ethnicity--a homogeneous relationship? Atheroscler Suppl (2006) 1.50

CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res (2007) 1.11

Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors? Circ Res (2015) 1.00

Cardiovascular risk. Br J Clin Pharmacol (2012) 0.97

A single nucleotide polymorphism in the stromal cell-derived factor 1 gene is associated with coronary heart disease in Chinese patients. Int J Mol Sci (2014) 0.89

Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation (2016) 0.80

Screening for suspected coronary heart disease in patients, using integrated serum biochemical indices. J Epidemiol Community Health (2015) 0.78

Coronary heart disease and heart attacks, 1912-2010. Med Hist (2011) 0.78

The associations between serum biomarkers and stenosis of the coronary arteries. Oncotarget (2016) 0.75